Broadcast Date: November 7, 2025 | 1:00–2:00 p.m. Central
Price: FREE for members, $49 for nonmembers
View On-Demand Webinar
Webinar Summary
Follow the complete journey of a biocontrol product, from initial discovery through development, scale-up, and market launch. This session unpacks the practical steps of commercialization and the regulatory requirements that shape product success at each stage. Participants will gain an integrated understanding of how research and development, business strategy, and regulatory planning work together to bring innovative biological solutions to market in a responsible and efficient manner. Whether you are advancing early-stage research or preparing for product registration, you’ll leave with clear insights to support every step of the commercialization pathway.
Learning Objectives
Attendees will be able to:
- recognize the current global market landscape, trends, and opportunities for biocontrol products.
- know the key regulatory requirements for biocontrol agents in various regions.
- identify pathways to achieve compliance with regulatory standards.
- grasp the common barriers to scaling production.
- apply lessons from case studies to overcome challenges in the production, marketing, or adoption of biocontrol agents.
- develop strategies for translating research innovations into commercially viable biocontrol products.
About the Presenters
Moderators:
- Devanshi Khokhani, University of Minnesota
- David Hubert, Indigo Ag
- Cecilia Freitas, Corteva Agriscience
Jennifer Lilly | The Mosaic Company
Jennifer is the Director of Regulatory for Biosciences at The Mosaic Company. She has over 20 years of experience working in agriculture, in both research, product stewardship, and regulatory. She has driven regulatory efforts for chemical, biological, and consumer products, and is actively involved in ag industry groups, including BPIA where she currently serves as Board Chair.
Linda Kinkel | Jord BioScience
Linda Kinkel earned an M.S. and Ph.D. in Plant Pathology and an M.S. in Biometry at UW–Madison, then completed postdoctoral research in microbial ecology at UC Berkeley. She is a faculty member in Plant Pathology at the University of Minnesota and founder and Chief Science Officer of Jord BioScience. Her Minnesota research focused on practical strategies to manage plant microbiome ecology and evolution to improve crop health and yield. After three decades of research, teaching, and service, she launched Jord to translate her team’s findings to real-world use, launching Jord BioScience. Jord partners with ag companies to enhance the effectiveness and consistency of microbial inoculants. Linda has also led the NSF-funded International Agricultural Microbiomes RCN; chaired the APS Public Policy Board; served as associate/senior editor for multiple journals and Associate Editor-in-Chief of
Phytobiomes Journal; and was elected an APS Fellow in 2018.
About the Webinar Series
Many APS members excel in research but face challenges translating scientific innovations into market-ready solutions. This series will offer practical guidance for commercialization. Interested folks will understand the regulatory pathways for biocontrol agents, especially given the complexities of international markets, are vital for researchers and developers. With the increasing emphasis on sustainability, this series will educate participants on aligning biocontrol innovations with current market needs and consumer trends. By connecting researchers, industry leaders, and policymakers, the series will foster partnerships that can accelerate the adoption of biocontrol solutions. Overall, the series will provide a platform for knowledge exchange and practical guidance and will empower APS members to contribute to sustainable agricultural practices and enhance their impact on global food security.
Learning Objectives
Attendees will be able to:
- recognize the current global market landscape, trends, and opportunities for biocontrol products.
- know the key regulatory requirements for biocontrol agents in various regions.
- identify pathways to achieve compliance with regulatory standards.
- grasp the common barriers to scaling production.
- apply lessons from case studies to overcome challenges in the production, marketing, or adoption of biocontrol agents.
- develop strategies for translating research innovations into commercially viable biocontrol products.
